Share Based Compensation Arrangements by Share Based Payment Award Options Expiration Term
Contractual term of awards
The period of time, from the grant date until the time at which the share-based (option) award expires.
Share Based Compensation Arrangement by Share Based Payment Award, Period From Termination Date of Optionee for Repurchase of Shares
Period from the termination date of option during which the entity has the right and option to purchase the shares of common stock under the 2005 Stock Plan
Represents the period from the termination date of option in which the entity has the right and option to purchase the shares of common stock obtained by the optionee through the exercise of award.
Restricted Stock that Vest on Periodic Basis over Specified Period [Member]
Award that vests on a quarterly basis over a four-year period
Represents the restricted stock award that vests on a periodic basis over a specified period.
Restricted Stock that Vest upon Achievement of Specified Milestones [Member]
Award that vests upon achievement of specified clinical and regulatory milestones
Represents the restricted stock award that vests upon achievement of specified milestones.
Award Grant Date [Axis]
Information pertaining to different grant dates of stock options granted to employees and non-employees.
Represents information pertaining to different grant dates of stock options granted to employees and non-employees.
Award Grant Date [Domain]
Award Type [Axis]
Vesting [Domain]
Stock based and other awards that vest under certain conditions
Grant Date One [Member]
01/19/2009
Represents the grant date one.
Grant Date Two [Member]
12/15/2009
Represents the grant date two.
Grant Date Three [Member]
02/10/2010
Represents the grant date three.
Amendment Description
Grant Date Four [Member]
04/16/2010
Represents the grant date four.
Amendment Flag
Grant Date Five [Member]
07/20/2010
Represents the grant date five.
Grant Date Six [Member]
10/15/2010
Represents the grant date six.
Grant Date Seven [Member]
11/02/2010
Represents the grant date seven.
Grant Date Eight [Member]
11/16/2010
Represents the grant date eight.
Grant Date Nine [Member]
10/14/2011
Represents the grant date nine.
Grant Date Ten [Member]
12/30/2011
Represents the grant date ten.
Grant Date Eleven [Member]
01/17/2012
Represents the grant date eleven.
Arrangements and Non-arrangement Transactions [Domain]
Grant Date Twelve [Member]
05/02/2012
Represents the grant date twelve.
Grant Date Thirteen [Member]
06/21/2012
Represents the grant date thirteen.
Share Based Compensation Arrangement by Share Based Payment Award Number of Options Repriced
Number of options repriced (in shares)
Represents the number of option awards of which the weighted-average exercise price was repriced.
Share Based Compensation Arrangements by Share Based Payment Award Options Grants in Period Weighted Average Exercise Price before Repricing
Per-share exercise price of options granted, before repricing (in dollars per share)
Represents the weighted-average price before repricing of options granted at which grantees can acquire the shares reserved for issuance on stock options awarded.
Share Based Compensation Arrangements by Share Based Payment Award Options Grants in Period Weighted Average Exercise Price after Repricing
Per-share exercise price of options granted, after repricing (in dollars per share)
Represents the weighted-average price after repricing of options granted at which grantees can acquire the shares reserved for issuance on stock options awarded.
Share Based Compensation Arrangement by Share Based Payment Award for which Performance Vesting Requirements Modified
Awards for which performance vesting requirements are modified (in shares)
Represents the number of awards under the stock compensation plan for which performance vesting requirements are modified.
Share Based Compensation Arrangement by Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate
Expected forfeiture rate (as a percent)
Represents the expected forfeiture rate assumption used in estimating the fair value of award.
Share Based Compensation Arrangement by Share Based Payment Award Options Granted [Abstract]
Stock options granted to employees and non-employees
Share Based Compensation Arrangement by Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract]
Weighted-Average Remaining Contractual Term
Current Fiscal Year End Date
Share Based Compensation Arrangement by Share Based Payment Award Equity Instruments Other than Options Number of Milestones to be Completed for Vesting of Unvested Shares
Number of milestones to be successfully completed for vesting of unvested shares
Represents the number of milestones to be successfully completed for vesting of non-vested awards.
Share Based Compensation Arrangement by Share Based Payment Award, Equity Instruments Other than Options Grants in Period Total Fair Value
Total estimated fair value
The total fair value of equity-based awards granted under the stock-based compensation plan.
Number of directors that shall not be changed without affirmative vote of two-thirds of outstanding shares of series A preferred stock
Represents the number of directors that shall not be changed without affirmative vote of a specified percentage of outstanding shares of preferred stock.
Preferred Stock Number of Directors that Shall Not be Changed without Specified Minimum Affirmative Voting Percentage
Preferred Stock Maximum Indebtedness that Can be Incurred without Specified Minimum Affirmative Voting Percentage
Maximum liability for indebtedness that can be incurred without affirmative vote of two-thirds of outstanding shares of series A preferred stock
Represents the maximum liability for indebtedness that can be incurred without affirmative vote of a specified percentage of outstanding shares of preferred stock.
Number of Votes Per Common Share Held
Number of votes to which holders of common shares are entitled for each share held
Represents the number of votes to which the holders of common stock are entitled for each share held.
Deferred financing costs
The tax effect, as of the balance sheet date, of the amount of the estimated future tax deductions arising from deferred financing costs, which can only be deducted for tax purposes when relevant losses are realized or actual obligations are incurred, and which can only be realized if sufficient tax-basis income is generated in future periods to enable the deduction to be taken.
Deferred Tax Assets Tax Deferred Expenses Deferred Financing Costs
Collaborative Arrangement Pre Commercial Milestone Payments Received
Represents the amount of pre-commercial milestone payments received by the entity under the license agreement.
Pre-commercial milestone payments received
Especificos Stendhal [Member]
Represents information pertaining to Especificos Stendhal, S.A., DE C.V., with whom the entity has entered into a developmental and licensing agreement.
Stendhal License
Represents information pertaining to United Therapeutics, with whom the entity has entered into a license agreement.
United Therapeutics
United Therapeutics [Member]
Equity interest sold (as a percent)
Percentage of subsidiary's or equity method investee's stock sold by the parent.
Subsidiary or Equity Method Investee Percentage of Equity Interest Sold
Reverse Stock Split
Reverse Stock Split
Document Period End Date
Royalty Revenue Period from Signing of License Amendment within which Royalty Payments is Committed to be Paid
Period from signing the amendment within which one-time payment is committed to be paid by Shire plc
Represents the period from signing the amendment to the license agreement within which royalty amount is committed to be paid by counterparty.
Mutual funds for SERP
Represents the investments made for the defined benefit plan by the entity.
Mutual Funds for Defined Benefit Plan [Member]
TCD Royalty Sub LLC [Member]
TCD
Represents information pertaining to TCD Royalty Sub, LLC, a disposal group of the entity.
Number of unrelated companies from which royalty payment rights and other license rights under license agreements were transferred
Represents number of unrelated entities from which royalty payment rights and other license rights under license agreements were transferred.
License Agreement Number of Unrelated Entities from whom Royalty Payment Rights and Other License Rights Transferred
Represents the amount of consideration payable for transfer of royalty payment rights and other license rights under license agreements.
License Agreement Consideration for Transfer of Royalty Payments Rights and Other License Rights
Consideration for transfer of royalty payment rights and other license rights under license agreements
Disposal Groups Including Discontinued Operations Servicing Agreement Quarterly Servicing Fee to be Received
Quarterly servicing fee to be received for performance of services related to the collection of amounts due in connection with license agreements
Represents the amount of quarterly servicing fee to be received by the entity under the servicing agreement executed by the entity in connection with the debt.
Represents the milestone payments to be received by the entity as a consideration for disposal of the disposal group that is classified as a component of the entity, upon achievement of certain milestones.
Disposal Group Including Discontinued Operation Contingent Consideration Milestone Payments
Contingent consideration to be received in future from sale of equity interest in TCD
Document and Entity Information
Development and Milestone Revenue
Development and milestone revenues
Revenue earned during the period through collaboration and research and development agreements. These agreements include fees for development services provided to customers, payments for achievement of specified development, regulatory and sales milestones, and to a lesser extent, upfront license payments, which comprise an entity's development and milestone revenue.
Organization and Nature of Operations
Number of product candidates receiving tentative approval
Number of Product Candidates Receiving Tentative Approval
Represents the number of product candidates of the entity, which received tentative approval from the Food and Drug Administration (the FDA).
Going Concern [Text Block]
Management's Plans as to Continuing as a Going Concern
The full disclosure for the going-concern plans.
Collaboration Agreements
Lab Equipment and Furniture [Member]
Lab equipment and furniture
Represents information pertaining to lab equipment and furniture.
Schedule of Property Plant and Equipment Components [Table Text Block]
Schedule of property and equipment
Tabular disclosure of the components of property, plant and equipment.
Debt Instrument, Period of Interest Only Payments
Represents the period of interest only payments.
Period of interest only payments
Debt Instrument, Prepayment Period [Axis]
Represents debt prepayment periods.
Debt Instrument, Prepayment Period [Domain]
Represents information pertaining to debt prepayment periods.
Debt Instrument, Prepayment Premium, Percentage
Represents the premium payable by the entity with respect to prepayment of outstanding debt, expressed as a percentage.
Prepayment premium (as a percent)
Debt Instrument, Required Final Payment
Represents the final payment that the entity will be required to make upon the maturity of any outstanding debt or the acceleration or prepayment thereof.
Final payment required to be made
Debt Instrument, Required Final Payment as Percentage of Aggregate Principal Amount
Represents the final payment as a percentage of aggregate principal amount that the entity will be required to make upon the maturity of any outstanding debt or the acceleration or prepayment thereof.
Final payment required to be made as a percentage of aggregate principal amount
Defined Benefit Plan, Number of Executives
Represents the number of executives for whom the entity has established a defined benefit plan.
Number of executives for whom SERP was established
Fair Value Inputs, Probability of Scenarios
Represents the probability of scenarios used to calculate fair value.
Probability (as a percent)
IPO Priced below Recommended Valuation Range [Member]
Represents the scenario when IPO is priced below recommended valuation range.
IPO priced below recommended valuation range
IPO priced within recommended valuation range
IPO Priced within Recommended Valuation Range [Member]
Represents the scenario when IPO is priced within recommended valuation range.
Lab and office equipment
Lab and Office Equipment [Member]
Represents information pertaining to lab and office equipment.
Marketable Securities Restricted [Policy Text Block]
Disclosure of accounting policy for restricted marketable securities.
Marketable Securities-Restricted
Preclinical Study and Clinical Trial Accruals and Deferred Advance Payments [Policy Text Block]
Disclosure of accounting policy for preclinical study and clinical trial accruals and deferred advance payments.
Preclinical Study and Clinical Trial Accruals and Deferred Advance Payments
Preferred Equity Financing Followed by IPO within Valuation Range [Member]
Represents the scenario of preferred equity financing followed by IPO within valuation range.
Preferred equity financing followed by IPO within valuation range
Preferred Equity Financing with Royalty Monetization Followed by IPO within Valuation Range [Member]
Represents the scenario of preferred equity financing with royalty monetization followed by IPO within valuation range.
Preferred equity financing with royalty monetization, followed by IPO within valuation range
Prepayment Period, 15 Months after Amortization Date [Member]
Represents the prepayment period of 15-months after the amortization date.
15-month period after the amortization date
Prepayment Period, before Amortization Date [Member]
Represents prepayment period before amortization date.
Before the amortization date
Prepayment Period, Thereafter [Member]
Represents the prepayment period after 15-months from the amortization date.
Thereafter
Probability Weighted Expected Return Method [Member]
Represents probability-weighted expected return method used to measure fair value.
PWERM
Revenue Recognition, Development Revenue Maximum Term of Contracts
Represents the maximum term of contracts under which development revenues have been earned by the entity.
Maximum duration of contracts under which development revenues have been earned
Scenario. [Axis]
Represents information by scenario used to calculate fair value.
Scenario [Domain]
Represents scenarios used by the entity to calculate fair value.
Term Loan Initial [Member]
Represents the initial term loan under credit facility.
Initial term loan facility
Term Loan Additional [Member]
Represents the additional term loan under amended credit facility.
Additional term loan after amendment
Warrant Liability [Policy Text Block]
Disclosure of accounting policy for warrant liability.
Warrant Liability
Warrant to Purchase Common Stock [Member]
Security that gives the holder the right to purchase shares of common stock in accordance with the terms of the instrument, usually upon payment of a specified amount.
Warrants to purchase common stock
Common stock warrant
Warrant to Purchase Preferred Stock [Member]
Security that gives the holder the right to purchase shares of Series A preferred stock in accordance with the terms of the instrument, usually upon payment of a specified amount.
Warrants to purchase Series A Preferred Stock
Preferred stock warrant
Number of Product Candidates for Attaining Marketing Approval
Number of most advanced product candidates for which the company is currently focused on attaining marketing approval
Represents the number of product candidates for which the entity is focused on attaining marketing approval and bringing them into market.
Minimum Number of Products Until Establishment of which in Marketplace Operating Losses is Expected to Continue
Minimum number of products to be established in the market to avoid operating losses
Represents the number of products to be established in the market to avoid operating losses.
Reverse Stock Split [Policy Text Block]
Reverse Stock Split
Disclosure of accounting policy for reverse stock split.
Basis of Presentation [Abstract]
Basis of Presentation
Disposal Groups Including Discontinued Operations Potential Milestone Payment Number of Days from Occurrence of Conditions
Number of days from occurrence of certain conditions to pay milestone payment
Represents the number of days from the occurrence of certain conditions to pay milestone payment to the reporting entity.
Disposal Groups Including Discontinued Operations Milestone Payment Condition One Minimum Royalty Payment to be Received by Purchaser
Minimum royalty payment to be received by purchaser for milestone payment
Represents the first condition for receiving milestone payment within the specified period of the occurrence of such conditions. This condition requires that the purchaser receive certain minimum amount of royalty payments along with certain other requirements that needs to be satisfied.
Disposal Groups Including Discontinued Operations Milestone Payment Condition Two Minimum Proceeds
Minimum proceeds to be received by purchaser for milestone payment
Represents the second condition for receiving milestone payment within the specified period of the occurrence of such conditions. This condition requires that the purchaser receives a minimum amount of proceeds along with certain other requirements that needs to be satisfied.
Disposal Groups Including Discontinued Operations Purchase Price Determination Minimum Number of Bidders Involved in Competitive Bidding Process
Minimum number of bidder involved in competitive bidding process to determine the purchase price
Represents the minimum number of bidder involved in competitive bidding for the determination of purchase price for disposal of the disposal group that is classified as a component of the entity.
Disposal Groups Including Discontinued Operations Servicing Agreement Annual Servicing Fee to be Received
Annual servicing fee to be received for performance of services related to the collection of amounts due in connection with license agreements
Represents the amount of annual servicing fee to be received by the entity under the servicing agreement executed by the entity in connection with the debt.
Disposal Group Including Discontinued Operation Sales Consideration Cash Payment
Cash payment to be received as consideration from sale of equity interest in TCD
Represents the cash consideration to be received by the entity as consideration for the disposal group.
Tenant and capital improvement allowances
Represents the amount of payments that the lessee can elect to make in connection with tenant and capital improvement allowances under the terms of an agreement classified as an operating lease.
Operating Leases Allowance for Tenant and Capital Improvement
Summary of Significant Accounting Policies
Represents the percentage increase in base annual rent due to amendment of the lease arrangement.
Operating Leases Base Annual Rent Increase Percentage
Percentage increase in base annual rent for the remaining term
Operating Leases Optional Lease Extension Period
Additional period for which the entity may elect to extend the term of the lease
Represents the additional period for which the entity may extend the operating lease term.
Entity Well-known Seasoned Issuer
Operating Leases Additional Allowance for Tenant and Capital Improvement
Additional tenant improvement allowance
Represents the additional amount of payments that the lessee can elect to make in connection with tenant and capital improvement allowances under the terms of an agreement classified as an operating lease.
Entity Voluntary Filers
Operating Leases Allowance for Tenant and Capital Improvement Capitalized
Tenant improvement allowance utilized and included in fixed assets and deferred rent
Represents the amount of allowances for tenant and capital improvements that have been utilized and capitalized by the entity.
Entity Current Reporting Status
Defined Contribution Plan Eligibility Minimum Age
Minimum age requirement for employees to participate in the plan
Represents the minimum eligibility age for employees to participate in the defined contribution plan.
Entity Filer Category
Accounts Payable and Accrued Liabilities, Current
Accounts payable and accrued expenses
Defined Contribution Plan Maximum Employee Contribution Percentage
Maximum contribution by employee (as a percent)
Represents the maximum contribution by eligible employee as a percentage of their eligible compensation, subject to the applicable limit established by the code.
Entity Public Float
Represents the vesting percentage of employee contribution.
Defined Contribution Plan, Percentage Vesting of Employee Contribution
Vesting percentage of contributions by employee to the 401(k) Plan
Entity Registrant Name
Defined Contribution Plan Employer Match Level One
Employer match of employee contributions on the first level of salary deferral (as a percent)
Represents the employer matching contribution of the first level of employee contributions.
Entity Central Index Key
Defined Contribution Plan Employer Match Employee Contribution Level One
Percentage of eligible compensation, first level, matched by employer
Represents the first level of employee contributions (percentage of compensation), which are matched by the employer.
Defined Contribution Plan Employer Match Level Two
Employer match of employee contributions on the second level of salary deferral (as a percent)
Represents the employer matching contribution of the second level of employee contributions.
Percentage of eligible compensation, second level, partially matched by employer
Represents the second level of employee contributions (percentage of compensation), which are partially matched by the employer.
Employer Match Employee Contribution Level Two
Defined Contribution Plan, Maximum Discretionary Employer Contribution Percentage
Maximum percentage of participating employee annual compensation that the company may elect to make a discretionary contribution
Represents the maximum percentage of participating employee annual compensation, that the employer may discretionary decide to contribute to a defined contribution plan.
Entity Common Stock, Shares Outstanding
Shire LLC [Member]
Shire LLC and its affiliates
Represents information pertaining to Shire LLC, a related party which holds series A preferred stock of the entity.
Royalty Opportunities S Arl [Member]
ROS
Represents information pertaining to Royalty Opportunities S.ar.1, a related party which is an affiliate of one of the entity's series A preferred stockholders.
Related Party Transaction Royalty Payment Received
Lump-sum payment received in return for a fully paid-up license for one of the products that utilizes the entity's proprietary technologies
Represents the lump-sum payment received in return for a fully paid-up license for one of the products that utilizes the entity's proprietary technologies.
Represents the maximum amount of additional milestones payments to be received by the entity under the collaborative agreement.
Future milestone payment to be received, based on certain milestones defined in the license agreement
Collaborative Arrangement Additional Milestone Payments Maximum
Collaborative Arrangement Expiration Period from First Commercial Sale of Product
Represents the expiration period of license agreement from the first commercial sale of each product on a country-by-country and product-by-product basis.
Expiration period from the first commercial sale of each product on a country-by-country and product-by-product basis
Milestone payments to be received upon development of additional treprostinil products for a second indication
Collaborative Arrangement Milestone Payments to be Received upon Satisfaction of Development Milestones of Additional Products for Second Indication
Represents the amount to be received by the entity upon satisfaction of development milestones of additional products for the second indication.
Represents the amount to be received by the entity upon satisfaction of development milestones of the product.
Milestone payments to be received upon development of oral treprostinil in PAH
Collaborative Arrangement Milestone Payments to be Received upon Satisfaction of Development Milestones of Product
Shares issued in connection with the purchase of certain assets from Shire Laboratories, Inc.
Number of shares issued during the period pursuant to acquisitions.
Preferred Stock Shares Issued Acquisitions
Convertible Preferred Stock Initial Conversion Ratio
Initial conversion ratio
Represents the ratio applied to the shares of preferred stock for the purpose of determining the number of shares of the common stock into which the shares of preferred stock will be converted.
Conversion ratio after giving effect to the reverse stock split
Represents the ratio used for determining the number of shares of the common stock into which the shares of preferred stock will be converted after giving effect to the reverse stock split.
Convertible Preferred Stock Conversion Ratio after Effect of Reverse Stock Split
Preferred Stock Voting Rights Number of Directors that Can be Elected
Number of directors the holders of series A preferred stock are entitled to elect
Represents the number of directors that can be elected by the preferred stockholders.
Minimum voting percentage of outstanding shares of series A preferred stock required for material changes
Represents the minimum voting percentage of shares of preferred stock required for material changes.
Preferred Stock Minimum Voting Rights Percentage Required for Material Changes
Tabular disclosure of the options granted during the period by the entity under the stock incentive plan.
Schedule of Options Granted [Table Text Block]
Schedule of stock options granted to employees and non-employees
Stock Plan 2005 [Member]
2005 Plan
Represents information pertaining to the 2005 Stock Plan that provides for grants of stock options, purchase rights and awards to employees, officers, directors, consultants or advisors.
Equity Incentive Plan 2012 [Member]
2012 Plan
Represents information pertaining to the 2012 Equity Incentive Plan that provides for grants of stock options, purchase rights and awards to employees, officers, directors, consultants or advisors.
Number of annual installments in which the awards would generally vest starting on the first anniversary of the date of grant
Share Based Compensation Arrangement by Share Based Payment Award Award Vesting Number of Installments from First Anniversary of Grant Date
Represents the number of installments in which the awards would generally vest starting from the first anniversary of the date of grant.
Document Fiscal Year Focus
Number of Late Stage Epilepsy Product Candidates
The number of late-stage epilepsy product candidates.
Number of late-stage epilepsy product candidates for which the company is currently focused on attaining regulatory approval
Document Fiscal Period Focus
Represents the amount of the estimated annual aggregate amortization expense.
Finite Lived Intangible Assets Estimated Annual Aggregate Amortization Expense
Estimated annual aggregate amortization expense through December 31, 2015
Revision of Commercial Plan Number of Late Stage Epilepsy Product Candidates
Number of late-stage epilepsy product candidates for which the company will likely revise its commercial plans
Represents the number of late-stage epilepsy product candidates for which the entity will likely revise its commercial plans in the event the entity does not access funding to continue operations and to fund deficits.
Number of product candidates which received tentative approval from the Food and Drug Administration (the FDA)
Represents the number of product candidates which received tentative approval from the prescribed authority.
Number of Product Candidates which Received Tentative Approval
Allocated Share Based Compensation Expense, Credit
Stock-based compensation (credit) recognized
Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.
Vesting [Axis]
Information about certain conditions that allow an award to vest
Proceeds from Issuance Initial Public Offering Net
Represents the net proceeds from issuance of stock, after deducting financing costs.
Net cash proceeds from sale of common stock
Pro Forma Balance Sheet Presentation [Policy Text Block]
Pro Forma Balance Sheet Presentation
Disclosure of accounting policy for presentation of pro forma balance sheet.
Tabular disclosure of the numerators and the denominators of the pro forma basic and diluted per-share (or per-unit) computations for income from continuing and discontinued operations.
Schedule of Proforma Earnings Per Share [Table Text Block]
Schedule of pro forma earnings (loss) per common share
Pro Forma Balance Sheet Presentation [Abstract ]
Pro Forma Balance Sheet Presentation
Convertible Preferred Stock Shares Issued upon Conversion Pro Forma
Number of shares of common stock into which Series A preferred stock are expected to automatically convert
Number of shares expected to be issued for convertible preferred stock as if the conversion has been completed at the beginning of the period.
Significant Accounting Policies [Line Items]
Summary of significant accounting policies
Deferred financing costs related to the IPO
Represents the carrying amount as of the balance sheet date of capitalized costs associated with the initial public offering that will be charged against the proceeds received from initial public offering.
Deferred Finance Costs Related to Initial Public Offering
Document Type
Schedule of Earnings Per Share [Table]
A table or schedule providing information pertaining to earnings per share.
Earnings Per Share [Line Items]
Pro forma earnings (loss) per common share
Preferred Stock Voting Percentage Required for Conversion
Voting percentage required for the right to elect to convert all outstanding shares into shares of common stock
Represents the voting percentage required to have the right to elect to convert all outstanding shares of preferred stock into shares of common stock.
Share Based Compensation Arrangement by Share Based Payment Award Number of Plans
Number of share-based compensation plans
Represents the number of share-based compensation plans of the entity.
Accounts receivable
Accounts Receivable, Net, Current
Summary of Significant Accounting Policies [Table]
Tabular disclosure providing information pertaining to significant accounting policies of the entity.
Number of Product Candidates Approved for Sale
Number of product candidates approved for sale
Represents the number of product candidates approved for sale.
Security that gives the holder the right to purchase shares of Series A preferred stock or common stock in accordance with the terms of the instrument, usually upon payment of a specified amount.
Warrant to Purchase Preferred Stock and Common Stock [Member]
Warrants to purchase Series A Preferred Stock/Common Stock
Grant Date Fourteen [Member]
8/9/2012
Represents the grant date fourteen.
Stock Issued During Period Shares New Issues Excluding Allotment
Number of shares issued, excluding underwriter over-allotment
Number of new share issued during the period, excluding shares issued to underwriters under their over-allotment option.
Issuance of common stock, net of offering costs (in shares)
Proceeds from Issuance Initial Public Offering Gross
Proceeds from issuance of common stock
The aggregate proceeds from entity's first offering of stock to the public, before financing costs.
Class of Warrant or Right Number of Shares Issued on Warrants Exercised
Number of shares issued on exercise of warrants
Represents the number of shares of common stock issued on exercised of warrants.
Number of Patents Issued
Number of patents issued by the U.S. Patent and Trademark Office
Represents the number of patents issued by the U.S. Patent and Trademark Office to the entity.
Class of Warrant or Right Number of Warrants Exercised
Number of warrants exercised
Represents the number of warrants exercised.
Number of Proprietary Products that Address Large Market Opportunities in Epilepsy and Attention Deficit Hyperactivity Disorder
Number of proprietary products that address large market opportunities in epilepsy and attention deficit hyperactivity disorder
Represents the number of proprietary products that address large market opportunities in epilepsy and attention deficit hyperactivity disorder.
Stock Options and Employee Stock Purchase Plan Awards [Member]
Stock options, Non-Vested Stock Options and ESPP Awards
Represents stock options and employee stock purchase plan.
Collaborative Arrangement Amount Received to be Recognized as Revenue on Straight Line Basis Over Obligation Period
Represents the amount received in collaborative arrangement to be recognized as revenue on a straight-line basis over obligation period.
Amount received to be recognized as revenue on a straight-line basis
Marketable Securities Current Portion
Marketable securities - noncurrent
Total debt and equity financial instruments including: (1) securities held-to-maturity, (2) trading securities, and (3) securities available-for-sale which are intended to be held for short period or the normal operating cycle, whichever is longer.
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss) [Member]
Less accumulated depreciation and amortization
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Accumulated Other Comprehensive Income (Loss), Net of Tax
Accumulated other comprehensive income (loss)
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life
Weighted-Average Life
Estimated useful lives of the patents
Acquired Finite-Lived Intangible Assets [Line Items]
Purchased patents
Additional paid-in capital
Additional Paid in Capital
Additional Paid-in Capital [Member]
Additional Paid-in Capital
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Adjustments to reconcile income (loss) from continuing operations to net cash provided by (used in) operating activities:
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs
Deferred Financing Costs
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition
Stock-based compensation
Allocated Share-based Compensation Expense
Stock-based compensation recognized
Stock compensation recognized
Amortization of Intangible Assets
Amortization expense
Amortization of deferred financing costs
Amortization of Financing Costs and Discounts
Common stock equivalents excluded in the calculation of diluted loss per share
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Loss per share
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities, Name [Domain]
Antidilutive Securities [Axis]
Total assets at fair value
Assets, Fair Value Disclosure
Current assets:
Assets, Current [Abstract]
Assets
Assets [Abstract]
Assets of discontinued operations
Assets of Disposal Group, Including Discontinued Operation, Noncurrent
Total current assets
Assets, Current
Total assets
Assets
Assets:
Assets, Fair Value Disclosure [Abstract]
Assets of discontinued operations (including restricted cash)
Assets of Disposal Group, Including Discontinued Operation, Current
Available-for-sale Securities, Fair Value Disclosure
Fair Value
Available-for-sale Securities, Gross Unrealized Gain (Loss)
Unrealized Gains (Losses)
Available-for-sale Securities, Amortized Cost Basis
Amortized Cost
Available-for-sale Securities, Noncurrent
Long Term Investments
Basis of Presentation
Basis of Accounting, Policy [Policy Text Block]
Cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Cash and Cash Equivalents, at Carrying Value
Cash and Cash Equivalents and Restricted Cash
Cash and Cash Equivalents, Policy [Policy Text Block]
Net change in cash and cash equivalents
Cash and Cash Equivalents, Period Increase (Decrease)
Cash and cash equivalents
Cash and Cash Equivalents, Fair Value Disclosure
Net cash provided by (used in) financing activities from discontinued operations
Cash Provided by (Used in) Financing Activities, Discontinued Operations
Net cash (used in) provided by operating activities from discontinued operations
Cash Provided by (Used in) Operating Activities, Discontinued Operations
Net cash provided by disposal of discontinued operations
Cash Provided by (Used in) Investing Activities, Discontinued Operations
Chief Executive Officer [Member]
Chief executive officer
Class of Warrant or Right [Table]
Warrant liability
Class of Warrant or Right [Line Items]
Class of Warrant or Right [Domain]
Class of Stock [Line Items]
Stockholders' equity
Class of Warrant or Right [Axis]
Exercise price (in dollars per share)
Class of Warrant or Right, Exercise Price of Warrants or Rights
Class of Stock [Domain]
Number of shares that can be purchased from warrants
Class of Warrant or Right, Number of Securities Called by Warrants or Rights
Collaboration agreement
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Collaborative Arrangement Disclosure [Text Block]
Collaboration Agreements
Collaboration agreements
Collaborative Arrangement [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Domain]
Collaborative Arrangements and Non-collaborative Arrangements [Axis]
Commitments and Contingencies
Commitments and Contingencies Disclosure [Text Block]
Commitments and Contingencies
Common Stock [Member]
Common Stock
Common stock, shares outstanding
Common Stock, Shares, Outstanding
Common stock, $0.001 par value-62,000,000, 62,625,000 and 130,000,000 shares authorized at December 31, 2010 and 2011 and September 30, 2012, respectively; 1,592,762, 1,662,321 and 24,466,049 shares issued and outstanding at December 31, 2010 and 2011 and September 30, 2012, respectively
Common Stock, Value, Issued
Common stock, shares issued
Common Stock, Shares, Issued
Common stock, par value (in dollars per share)
Common Stock, Par or Stated Value Per Share
Common stock, shares authorized
Common Stock, Shares Authorized
Common Stock, Capital Shares Reserved for Future Issuance
Common stock reserved for the potential conversion of outstanding series A preferred stock
Employee Benefit Plan
Deferred tax assets:
Components of Deferred Tax Assets [Abstract]
Components of the benefit from income tax
Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]
Components of the Company's deferred tax assets (liabilities)
Components of Deferred Tax Assets and Liabilities [Abstract]
Comprehensive income (loss):
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Total comprehensive income (loss)
Comprehensive income (loss)
Comprehensive Income [Member]
Computer equipment
Computer Equipment [Member]
Concentration of Credit Risk
Concentration Risk, Credit Risk, Policy [Policy Text Block]
Conversion of Stock, Shares Converted
Common stock automatically converted from Series A convertible preferred stock, shares
Conversion of Stock, Amount Converted
Non-cash conversion of preferred stock to common stock at par value
Number of shares of common stock into which Series A preferred stock automatically got converted
Convertible Preferred Stock, Shares Issued upon Conversion
Costs and Expenses [Abstract]
Costs and expenses
Costs and Expenses
Total costs and expenses
State
Current State and Local Tax Expense (Benefit)
Current
Current Income Tax Expense (Benefit), Continuing Operations [Abstract]
Federal
Current Federal Tax Expense (Benefit)
Notes payable
Debt Instrument [Line Items]
Schedule of Long-term Debt Instruments [Table]
Notes Payable
Debt Instrument, Decrease, Repayments
Amount paid in principal
Drawdown under the secured credit facility
Debt Instrument, Increase, Additional Borrowings
Funds raised from a completed private placement
Draw down under secured credit facility
Debt discount
Debt Instrument, Unamortized Discount
Fixed interest rate (as a percent)
Debt Instrument, Interest Rate, Stated Percentage
Interest rate (as a percent)
Depreciation and amortization
Deferred Tax Assets, Property, Plant and Equipment
Title of Individual [Axis]
Deferred Financing Costs
Deferred Charges, Policy [Policy Text Block]
Federal
Deferred Federal Income Tax Expense (Benefit)
Deferred revenue
Deferred Revenue
Deferred Financing Costs
Deferred Finance Costs [Abstract]
Deferred Finance Costs, Gross
Capitalized financing costs
Deferred financing costs, current
Deferred Finance Costs, Current, Net
Deferred
Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]
Deferred financing costs, long-term
Deferred Finance Costs, Noncurrent, Net
Deferred financing costs
Income tax benefit
Deferred Income Tax Expense (Benefit)
Net deferred tax asset
Deferred Tax Assets, Net of Valuation Allowance
Net deferred tax asset before valuation allowance
Deferred Tax Assets, Gross
State
Deferred State and Local Income Tax Expense (Benefit)
Deferred revenue, net of current portion
Deferred Revenue, Noncurrent
Deferred revenue
Deferred Revenue, Current
Net operating loss carryforward
Deferred Tax Assets, Operating Loss Carryforwards
Deferred rent credit
Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent
Research and development credits
Deferred Tax Assets, Tax Credit Carryforwards, Research
Other
Deferred Tax Assets, Other
Accrued compensation and non-qualified stock options
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits
Valuation allowance
Deferred Tax Assets, Valuation Allowance
Defined Benefit Plan, Current Assets
Marketable securities-restricted
Marketable securities - restricted
Defined Benefit Plans and Other Postretirement Benefit Plans [Axis]
Defined Benefit Plans and Other Postretirement Benefit Plans [Domain]
Company's contribution to the 401(k) Plan
Defined Contribution Plan, Cost Recognized
Defined Benefit Pension Plan, Liabilities, Noncurrent
Supplemental executive retirement plan
Depreciation and amortization
Depreciation, Depletion and Amortization
Depreciation expense
Depreciation
Derivative Liabilities, Noncurrent
Warrant liability
Warrant liability at fair value
Share-Based Payments
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
Share-Based Payments
Income tax expense from discontinued operations
Discontinued Operation, Tax Effect of Discontinued Operation
Gain on disposal of discontinued operations, net of tax
Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax
Gain on the sale of TCD, net of taxes
Pre-tax income from discontinued operations
Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax
Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax
Income (loss) from discontinued operations, net of tax
Loss (income) from discontinued operations
Sale of TCD Royalty Sub Reported as Discontinued Operations
Sale of TCD Royalty Sub Reported as Discontinued Operations
Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]
Disposal Groups, Including Discontinued Operations, Name [Domain]
Basic
Earnings Per Share, Basic [Abstract]
Net income (loss) (in dollars per share)
Earnings Per Share, Diluted
Net income (loss) per share (in dollars per share)
Diluted
Earnings Per Share, Diluted [Abstract]
Earnings Per Share, Basic and Diluted [Abstract]
Basic and Diluted
Basic and diluted Pro forma net income (loss) per common share:
Net income (loss) (in dollars per share)
Earnings Per Share, Basic
Earnings Per Share, Basic and Diluted
Net income (loss) (in dollars per share)
Earnings (Loss) Per Share
Earnings Per Share, Policy [Policy Text Block]
Income (loss) per common share:
Earnings Per Share [Abstract]
Employee-related Liabilities, Current
Accrued compensation
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition
Weighted-average period over which total unrecognized compensation expense is expected to be recognized
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Share-based Payments
ESPP
Employee Stock [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs, Report Line [Domain]
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized
Total unrecognized compensation expense, net of related forfeiture estimates
Manufacturing equipment
Equipment [Member]
Equity Component [Domain]
Estimate of Fair Value, Fair Value Disclosure [Member]
Total Carrying Value
Fair Value Assumptions, Expected Volatility Rate
Volatility (as a percent)
Fair Value, Hierarchy [Axis]
Liability Class [Axis]
Assumptions used to calculate fair value of common stock warrant liability using Monte-Carlo simulation on a Black-Scholes lattice model
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]
Balance at the beginning of the period
Balance at the end of the period
Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value
Fair Value Inputs, Liabilities, Quantitative Information [Table]
Risk-Free Rate (as a percent)
Fair Value Assumptions, Risk Free Interest Rate
Fair Value Measurements, Recurring and Nonrecurring [Table]
Fair Value by Liability Class [Domain]
Term
Fair Value Assumptions, Expected Term
Schedule of fair value of the financial assets and liabilities
Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]
Fair Value, Measurements, Fair Value Hierarchy [Domain]
Fair Value Assumptions, Exercise Price
Exercise Price (in dollars per share)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issues
Issuance of Series A Preferred Stock warrants
Schedule of assumptions used to calculate fair value of stock warrant liability using Monte-Carlo simulation on a Black-Scholes lattice model
Fair Value Inputs, Liabilities, Quantitative Information [Table Text Block]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of financial instruments
Fair Value Assumptions, Expected Dividend Rate
Dividend Yield (as a percent)
Fair Value of Financial Instruments
Fair Value of Financial Instruments, Policy [Policy Text Block]
Significant Unobservable Inputs (Level 3)
Fair Value, Inputs, Level 3 [Member]
Quoted Prices in Active Markets (Level 1)
Fair Value, Inputs, Level 1 [Member]
Significant Other Observable Inputs (Level 2)
Fair Value, Inputs, Level 2 [Member]
Changes in fair value of warrants included in earnings
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings
Warrant Liability
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Schedule of the entity's common stock warrant liability
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
Changes in fair value of the warrants
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]
Finite-Lived Intangible Assets, Major Class Name [Domain]
Finite-Lived Intangible Assets, Gross
Gross Carrying Amount
Finite-Lived Intangible Assets by Major Class [Axis]
Finite-Lived Intangible Assets, Accumulated Amortization
Accumulated Amortization
Finite-Lived Intangible Assets, Net [Abstract]
Intangible Assets
Furniture
Furniture and Fixtures [Member]
Gain on sale of property and equipment
Gain (Loss) on Sale of Property Plant Equipment
General and Administrative Expense [Member]
General and administrative
Purchased Patents
Impairment of Long-Lived Assets
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]
Discontinued operations (in dollars per share)
Income (Loss) from Discontinued Operations, Net of Tax, Per Basic Share
Consolidated Statements of Operations
Income Tax Disclosure [Text Block]
Income Taxes
Income Taxes
Income (Loss) from Discontinued Operations, Net of Tax, Per Basic and Diluted Share
Discontinued operations (in dollars per share)
Income (loss) from continuing operations
Income (loss) from continuing operations
Income (Loss) from Continuing Operations Attributable to Parent
(Loss) from continuing operations used to compute pro forma (loss) from continuing operations per common share-basic and diluted
Income (Loss) from Continuing Operations, Per Basic and Diluted Share
Continuing operations (in dollars per share)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Sale of TCD Royalty Sub reported as discontinued operations
Discontinued operations (in dollars per share)
Income (Loss) from Discontinued Operations, Net of Tax, Per Diluted Share
Net income (loss) per share from discontinued operations (in dollars per share)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Table]
Disposal Group Name [Axis]
Continuing operations (in dollars per share)
Income (Loss) from Continuing Operations, Per Basic Share
Income (Loss) from Continuing Operations, Per Diluted Share
Continuing operations (in dollars per share)
Income tax benefit
Income Tax Expense (Benefit)
Income tax benefit generated from the loss from continuing operations
Income tax benefit
Total
Income Tax Expense (Benefit), Continuing Operations
Income tax (benefit) computed at federal statutory tax rate
Income Tax Reconciliation, Income Tax Expense (Benefit), at Federal Statutory Income Tax Rate
Reconciliation of the expected income tax benefit computed using the federal statutory income tax rate to the Company's effective income tax rate
Income Tax Expense (Benefit), Continuing Operations, Income Tax Reconciliation [Abstract]
Permanent items
Income Tax Reconciliation, Nondeductible Expense
Change in valuation allowance
Net change in total valuation allowance due to the tax attributes utilized by discontinued operations
Income Tax Reconciliation, Change in Deferred Tax Assets Valuation Allowance
Research and development credits
Income Tax Reconciliation, Tax Credits, Research
State taxes
Income Tax Reconciliation, State and Local Income Taxes
Income Taxes
Income Tax, Policy [Policy Text Block]
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent [Abstract]
Discontinued Operations:
Uncertain tax position
Income Tax Reconciliation, Tax Contingencies
Other
Income Tax Reconciliation, Other Adjustments
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent
(Loss) income from discontinued operations
Loss (income) from discontinued operations
Income from discontinued operations used to compute pro forma income per common share-basic and diluted
Increase (Decrease) in Accrued Interest Receivable, Net
Interest receivable
Other non-current liabilities
Increase (Decrease) in Other Noncurrent Liabilities
Deferred revenue
Increase (Decrease) in Deferred Revenue
Accounts receivable
Increase (Decrease) in Accounts Receivable
Increase (Decrease) in Accounts Payable and Accrued Liabilities
Accounts payable, accrued expenses, and supplemental executive retirement plan
Changes in operating assets and liabilities:
Increase (Decrease) in Operating Capital [Abstract]
Prepaid expenses and other assets
Increase (Decrease) in Prepaid Expense and Other Assets
Inventory
Increase (Decrease) in Inventories
Interest payable
Increase (Decrease) in Interest Payable, Net
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Increase (Decrease) in Stockholders' Equity
Incremental Common Shares Attributable to Conversion of Preferred Stock
Potential common stock included in denominator for the per share amounts related to discontinued operations (in shares)
Purchased Patents
Intangible Assets Disclosure [Text Block]
Intangible Assets
Intangible Assets, Finite-Lived, Policy [Policy Text Block]
Purchased patents, net
Intangible Assets, Net (Excluding Goodwill)
Net book value of intangible assets
Interest Payable
Interest payable
Interest Payable, Current
Interest payable
Interest expense
Interest Expense
Interest expense
Interest Expense, Debt
Cash paid for interest-Discontinued operations
Interest Paid, Discontinued Operations
Interest receivable
Interest Receivable, Current
Cash paid for interest-Continuing operations
Interest Paid
Inventory, Policy [Policy Text Block]
Inventory
Inventory
Inventory, Net
Investment Income, Interest
Interest income
Marketable Securities
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]
Long-term Debt, Type [Domain]
Long-term Debt, Type [Axis]
Rent expense
Operating Leases, Rent Expense
Leasehold improvements
Leasehold Improvements [Member]
Total current liabilities
Liabilities, Current
Liabilities of Disposal Group, Including Discontinued Operation, Current
Current liabilities of discontinued operations
Current liabilities:
Liabilities, Current [Abstract]
Total liabilities
Liabilities
Liabilities of Disposal Group, Including Discontinued Operation, Noncurrent
Non-current liabilities of discontinued operations
Liabilities and stockholders' equity (deficit)
Liabilities and Equity [Abstract]
Liabilities:
Liabilities, Fair Value Disclosure [Abstract]
Total liabilities and stockholders' equity (deficit)
Liabilities and Equity
Maximum borrowing capacity
Line of Credit Facility, Maximum Borrowing Capacity
Aggregate amount
Long-term Debt
Total
Long-term Debt, Fiscal Year Maturity [Abstract]
Required principal payments
Long-term Debt [Text Block]
Notes Payable
Long-term Debt, Maturities, Repayments of Principal in Year Three
2014
Long-term Debt, Maturities, Repayments of Principal in Year Two
2013
Long-term Debt, Maturities, Repayments of Principal in Year Four
2015
Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months
2012
Major Types of Debt and Equity Securities [Axis]
Major Types of Debt and Equity Securities [Domain]
Marketable Securities
Marketable Securities, Policy [Policy Text Block]
Marketable Securities
Marketable Securities, Current
Marketable securities
Marketable securities-noncurrent
Marketable Securities, Noncurrent
Marketable securities - noncurrent
Marketable Securities, Unrealized Gain (Loss), Excluding Other than Temporary Impairments
Unrealized loss (gain) on marketable securities
Maximum
Maximum [Member]
Minimum
Minimum [Member]
Municipal Bonds [Member]
Municipal bonds
Nature of Operations [Text Block]
Organization and Nature of Operations
Net cash provided by (used in) operating activities from continuing operations
Net Cash Provided by (Used in) Operating Activities, Continuing Operations
Cash flows from financing activities
Net Cash Provided by (Used in) Financing Activities [Abstract]
Net cash (used in) provided by investing activities from continuing operations
Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Net income (loss) attributable to common stockholders
Net Income (Loss) Available to Common Stockholders, Basic
Net income (loss) attributable to common stockholders
Net cash (used in) provided by investing activities
Net Cash Provided by (Used in) Investing Activities
Numerator:
Net Income (Loss) Attributable to Parent [Abstract]
Net cash provided by (used in) financing activities
Net Cash Provided by (Used in) Financing Activities
Net cash provided by (used in) financing activities from continuing operations
Net Cash Provided by (Used in) Financing Activities, Continuing Operations
Cash flows from investing activities
Net Cash Provided by (Used in) Investing Activities [Abstract]
Operating activities
Net Cash Provided by (Used in) Operating Activities [Abstract]
Net income (loss)
Net income (loss)
Net Income (Loss) Attributable to Parent
Net cash provided by (used in) operating activities
Net Cash Provided by (Used in) Operating Activities
Recently Issued Accounting Pronouncements
New Accounting Pronouncements, Policy [Policy Text Block]
Nonoperating Income (Expense)
Total other income (expense)
Other income (expense):
Nonoperating Income (Expense) [Abstract]
Notes Payable, Other Payables [Member]
Notes
Non-recourse notes issued by TCD
Notes Payable, Fair Value Disclosure
Non-recourse notes payable, held in TCD
Number of Operating Segments
Number of business segments
Officer
Officer [Member]
Thereafter
Operating Leases, Future Minimum Payments, Due Thereafter
Future minimum lease payments under non-cancelable operating leases
Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]
NOL carryforwards
Operating Loss Carryforwards
Operating income (loss) from continuing operations
Operating Income (Loss)
2014
Operating Leases, Future Minimum Payments, Due in Three Years
2013
Operating Leases, Future Minimum Payments, Due in Two Years
2012
Operating Leases, Future Minimum Payments Due, Next Twelve Months
2015
Operating Leases, Future Minimum Payments, Due in Four Years
Total
Operating Leases, Future Minimum Payments Due
Basis of Presentation
Basis of Presentation
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
Other Comprehensive Income (Loss), Net of Tax
Other assets
Other Assets, Noncurrent
Other Nonoperating Income (Expense)
Other income (expense)
Other non-current liabilities
Other Liabilities, Noncurrent
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Other comprehensive income (loss)
Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent
Unrealized gains (losses) on marketable securities
Patents [Member]
Purchased patents
Payments of Stock Issuance Costs
Expenses incurred in connection with offering
Financing costs
Purchases of property and equipment, net
Payments to Acquire Property, Plant, and Equipment
Payments of Financing Costs
Financing costs and underwriters discounts
Employee Benefit Plan
Pension and Other Postretirement Benefits Disclosure [Text Block]
Plan Name [Domain]
Plan Name [Axis]
Series A convertible preferred stock, $0.001 par value-49,000,000, 49,625,000 and 65,000,000 shares authorized at December 31, 2010 and 2011 and September 30, 2012, respectively; 49,000,000, 49,000,000 and zero shares issued and outstanding at December 31, 2010 and 2011 and September 30, 2012, respectively; aggregate liquidation preference of $66,090, $69,520 and zero at December 31, 2010 and 2011 and September 30, 2012, respectively
Preferred Stock, Value, Issued
Series A convertible preferred stock, shares authorized
Preferred Stock, Shares Authorized
Series A convertible preferred stock, shares issued
Preferred Stock, Shares Issued
Cumulative dividends on Series A convertible preferred stock
Preferred Stock Dividends and Other Adjustments
Series A convertible preferred stock, par value (in dollars per share)
Preferred Stock, Par or Stated Value Per Share
Preferred Stock, Dividend Rate, Per-Dollar-Amount
Rate at which dividends accrued (in dollars per share)
Preferred Stock, Amount of Preferred Dividends in Arrears
Accumulated dividends
Series A convertible preferred stock, aggregate liquidation preference (in dollars)
Preferred Stock, Liquidation Preference, Value
Preferred Stock, Liquidation Preference Per Share
Price per share that the holders of preferred stock are entitled to receive in liquidation (in dollars per share)
Series A convertible preferred stock, shares outstanding
Preferred Stock, Shares Outstanding
Number of outstanding shares of Series A preferred Stock that are automatically converted to shares of common stock
Series A Convertible Preferred Stock
Preferred Stock [Member]
Prepaid expenses and other
Prepaid Expense and Other Assets, Current
Prepaid expenses
Prepaid Expense, Current
Weighted-average number of common shares used in calculating pro forma (loss) from continuing operations, income from discontinued operations and net income per common share: Diluted
Pro Forma Weighted Average Shares Outstanding, Diluted
Pro Forma [Member]
Pro Forma
Proceeds from Debt, Net of Issuance Costs
Net proceeds, net of financing costs and required interest reserve
Proceeds from issuance of common stock
Proceeds from Issuance of Common Stock
Proceeds from Issuance of Preferred Stock and Preference Stock
Aggregate gross cash proceeds
Net cash proceeds from sale of common stock
Proceeds from Issuance Initial Public Offering
Sales and maturities of marketable securities
Proceeds from Sale and Maturity of Marketable Securities
Proceeds from Secured Notes Payable
Proceeds from issuance of secured notes payable
Average useful lives
Property, Plant and Equipment, Useful Life
Property, Plant and Equipment, Type [Domain]
Property and Equipment
Property and Equipment
Property, Plant and Equipment, Policy [Policy Text Block]
Property and equipment, net
Property, Plant and Equipment, Net
Property and equipment, net
Property and equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross
Property, Plant and Equipment, Gross
Schedule of average useful lives used to compute depreciation and amortization
Property, Plant and Equipment [Table Text Block]
Property, Plant and Equipment, Type [Axis]
Property and Equipment
Property, Plant and Equipment Disclosure [Text Block]
Range [Axis]
Range [Domain]
Reconciliation of the beginning and ending amount of gross unrecognized tax benefits
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Related-Party Transactions
Related Party Transactions Disclosure [Text Block]
Related Party Transaction [Line Items]
Related party transaction
Related Party [Domain]
Related-Party Transactions
Related Party [Axis]
Repayments of secured notes payable
Repayments of Secured Debt
Research and development
Research and Development Expense
Research and Development Expense [Member]
Research and development
Research and Development Costs
Research and Development Expense, Policy [Policy Text Block]
Amount available in restricted cash interest reserve account to pay interest
Restricted Cash and Cash Equivalents
Cash and cash equivalents - restricted
Restricted Stock [Member]
Restricted award
Accumulated deficit
Retained Earnings (Accumulated Deficit)
Retained Earnings [Member]
Accumulated Deficit
Revenue Recognition
Revenue Recognition [Abstract]
Revenue Recognition
Revenue Recognition, Policy [Policy Text Block]
Milestone revenues recorded
Revenue Recognition, Milestone Method, Revenue Recognized
Revenues
Revenues [Abstract]
Management's Plans as to Continuing as a Going Concern
Royalty revenues related to an amendment to a license agreement with Shire plc
Royalty Revenue
Royalty revenues
Purchase price expressed as a percentage of fair market value of common stock
Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
Aggregate intrinsic value of options exercisable
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term
Vested and expected to vest
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term
Expected term
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term
Exercisable
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term
Outstanding at the end of the period
Revenue, Net
Total revenues
Scenario, Unspecified [Domain]
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]
Schedule of components of the benefit from income tax
Schedule of Nonvested Share Activity [Table Text Block]
Summary of activity related to non-vested shares
Summary of stock option activity
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
Schedule of assumptions used in estimation of fair value of each award option on the date of grant using Black-Scholes option-pricing model
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
Schedule of Available-for-sale Securities [Table]
Schedule of Maturities of Long-term Debt [Table Text Block]
Schedule of principal payments of secured notes payable
Schedule of common stock equivalents excluded in the calculation of diluted earnings (loss) per share
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]
Schedule of reconciliation of the expected income tax benefit computed using the federal statutory income tax rate to the entity's effective income tax rate
Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]
Schedule of reconciliation of the beginning and ending amount of gross unrecognized tax benefits
Schedule of future minimum lease payments under non-cancelable operating leases
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]
Schedule of Significant components of the entity's deferred tax assets (liabilities)
Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]
Schedule of gross carrying amount and related accumulated amortization of the patents
Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]
Schedule of Available-for-sale Securities [Line Items]
Marketable securities
Schedule of Available-for-sale Securities Reconciliation [Table Text Block]
Schedule of marketable securities
Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table]
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs, by Report Line [Axis]
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]
Schedule of stock-based compensation recognized related to the grant of employee and non-employee stock options, and non-vested stock
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]
Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]
Schedule of Related Party Transactions, by Related Party [Table]
Schedule of Property, Plant and Equipment [Table]
Schedule of Stock by Class [Table]
Secured Long-term Debt, Noncurrent
Secured notes payable, net of current portion and discount
Secured Debt, Current
Secured notes payable, net
Secured Debt [Member]
Term loans under secured credit facility
Term loans
Secured Debt
Principal amount outstanding
Selling, general and administrative
Selling, General and Administrative Expense
Series A Preferred Stock
Series A Preferred Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period
Requisite service period over which total estimated fair value was recognized
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Number of Shares
Stock-based compensation expense
Share-based Compensation
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
Granted (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum
Expected volatility, maximum (as a percent)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Forfeited or expired (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum
Expected volatility, minimum (as a percent)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Non-vested shares at the beginning of the period (in dollars per share)
Non-vested shares at the end of the period (in dollars per share)
Weighted-Average Exercise Price
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
Total fair value of the common stock vested
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period
Vesting period
Risk-free rate, maximum (as a percent)
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum
Weighted-Average Fair Value
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]
Number of Options Granted (in shares)
Granted (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Share-based payments
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Non-vested shares at the end of the period
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Non-vested shares at the beginning of the period
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period
Number of awards vested (in shares)
Vested (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
Forfeited or expired (in dollars per share)
Share Price
Stock Price (in dollars per share)
Fair value of common stock (in dollars per share)
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Exercise Price (in dollars per share)
Granted (in dollars per share)
Granted (in shares)
Number of awards granted (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum
Risk-free rate, minimum (as a percent)
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Exercised (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
Forfeited or expired (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Exercisable (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Expected dividends (as a percent)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
Vested (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Estimated Fair Value (in dollars per share)
Weighted-average, grant-date fair value of options granted (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Total Intrinsic Value
Total intrinsic value of options exercised
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Share-based payments, additional disclosure
Exercisable (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Number of Options
Maximum number of shares of common stock provided for issuance
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Assumptions used in estimating the fair value of each option award using the Black-Scholes option-pricing model
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
Forfeited or expired (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value
Intrinsic Value (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Plan Modification, Incremental Compensation Cost
Stock-based compensation related to the modified performance vesting options
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number
Vested and expected to vest (in shares)
Outstanding at the beginning of the period (in dollars per share)
Outstanding at the end of the period (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
Aggregate intrinsic value of options outstanding
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
Aggregate intrinsic value of options vested and expected to vest
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
Outstanding at the beginning of the period (in shares)
Outstanding at the end of the period (in shares)
Award Type [Domain]
Stock-Based Compensation
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
Vested and expected to vest (in dollars per share)
Shares, Outstanding
Balance (in shares)
Balance (in shares)
Significant Accounting Policies [Text Block]
Summary of Significant Accounting Policies
Software
Software [Member]
Statement [Table]
Scenario [Axis]
Statement
Statement [Line Items]
Consolidated Statements of Changes in Stockholders' Equity (Deficit)
Consolidated Statements of Cash Flows
Equity Components [Axis]
Consolidated Balance Sheets
Unaudited Consolidated Statements of Comprehensive Income (Loss)
Class of Stock [Axis]
Stock Issued During Period, Shares, Period Increase (Decrease)
Stock option
Stock Options [Member]
Stock Issued During Period, Value, Stock Options Exercised
Exercise of stock options
Stock Issued During Period, Value, New Issues
Issuance of common stock, net of underwriters' discount and offering costs
Stock Issued During Period, Shares, Other
Shares of common stock sold upon exercise of full amount of over-allotment option by the underwriters
Stock Issued During Period, Value, Conversion of Convertible Securities
Conversion of preferred stock to common stock
Stock Issued During Period, Shares, New Issues
Issuance of common stock, net of underwriters' discount and offering costs (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
Exercise of stock options (in shares)
Exercised (in shares)
Stock Issued During Period, Shares, Conversion of Convertible Securities
Conversion of preferred stock to common stock (in shares)
Vesting of unvested stock issued to officer
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures
Vesting of unvested stock issued to officer (in shares)
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures
Common stock purchased by eligible employees (in shares)
Stock Issued During Period, Shares, Employee Stock Purchase Plans
Stockholders' equity (deficit):
Stockholders' Equity Attributable to Parent [Abstract]
Total stockholders' equity (deficit)
Stockholders' Equity Attributable to Parent
Balance
Balance
Stockholders' Equity (Deficit)
Conversion ratio of reverse stock split
Stockholders' Equity Note, Stock Split, Conversion Ratio
Stockholders' Equity (Deficit)
Stockholders' Equity Note Disclosure [Text Block]
Stockholders' Equity, Period Increase (Decrease)
Subsequent Events [Text Block]
Subsequent Event
Subsequent Event
Subsequent Event Type [Domain]
Subsequent Event
Subsequent Event [Line Items]
Subsequent Event Type [Axis]
Subsequent Event [Table]
Subsequent event
Subsequent Event [Member]
Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions
Ownership interest (as a percent)
Supplemental cash flow information:
Supplemental Cash Flow Information [Abstract]
Supplemental Employee Retirement Plans, Defined Benefit [Member]
Supernus Executive Retirement Plan (SERP)
Research and development credit carryforwards
Tax Credit Carryforward, Amount
Title of Individual with Relationship to Entity [Domain]
Trade and Other Accounts Receivable, Policy [Policy Text Block]
Accounts Receivable
Type of Arrangement and Non-arrangement Transactions [Axis]
Unrealized Gain (Loss) on Derivatives
Change in fair value of warrant liability
Changes in fair value of warrants included in other income (expense)
Gross increases related to current-year tax positions
Unrecognized Tax Benefits, Increases Resulting from Current Period Tax Positions
Balance at the beginning of the period
Balance at the end of the period
Unrecognized Tax Benefits
Gross increases related to prior-year tax positions
Unrecognized Tax Benefits, Increases Resulting from Prior Period Tax Positions
Use of Estimates
Use of Estimates, Policy [Policy Text Block]
US Government Agencies Debt Securities [Member]
U.S. Agency Securities
US Treasury and Government [Member]
U.S. Treasuries and agencies
Net change in total valuation allowance due to the tax attributes utilized by discontinued operations
Valuation Allowance, Deferred Tax Asset, Change in Amount
Valuation Technique [Axis]
Valuation Technique [Domain]
Warrants
Warrant [Member]
Warrants outstanding
Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Weighted-average number of common shares:
Denominator:
Basic (in shares)
Weighted Average Number of Shares Outstanding, Basic
Weighted-average number of common shares used to calculate (loss) from continuing operations, income from discontinued operations and net income per common share: Basic
Add: Pro forma adjustments to reflect assumed weighted-average effect of conversion of convertible preferred stock
Weighted Average Number Basic Shares Outstanding Adjustment, Pro Forma
Diluted (in shares)
Weighted Average Number of Shares Outstanding, Diluted
Weighted-average number of common shares used to calculate (loss) from continuing operations, income from discontinued operations and net income per common share: Diluted
Weighted-average number of common shares used in calculating pro forma (loss) from continuing operations, income from discontinued operations and net income per common share: Basic
Weighted Average Basic Shares Outstanding, Pro Forma
Write off of Deferred Debt Issuance Cost
Deferred financing costs eliminated
Maximum maturiites of noncurrent marketable securities
Marketable Securities Noncurrent Maximum Period
The maximum maturity of the marketable security in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
Number of Venture Debt Holders Exercising Warrants
The number of venture debt holders exercising warrants in period.
Number of venture debt holders exercising warrants
Reverse Stock Split [Text Block]
Reverse Stock Split
The entire disclosure of reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.
Collaboration agreement substantive obligation period
Collaboration Agreement Substantive Obligation Period
Represent the substantive obligation period for the collaboration agreement.
Pre-Effective Amendment Number